Article · 19 Jun 2026
ArticlePublished 16 Sep 2024
A Case of Female Osteoporosis: A 50-Year-Old Postmenopausal Woman with Zoledronic Acid-Induced Uveitis
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Zoledronic Acid (ZA) is a third-generation bisphosphonate, most commonly used for the treatment of several conditions like postmenopausal osteoporosis, metastatic disease to the bone, hypercalcemia, Paget’s disease and multiple myeloma. In this study, we describe a 50-year-old lady who developed eye pain and redness after zoledronic acid infusion, given for controlling hypercalcemia, when she presented with hypercalcemia induced pancreatitis.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Pharmacovigilance.
Article · 19 Jun 2026
Strengthening Healthcare Outcomes Through Effective Drug Safety Practices
Article · 19 Jun 2026
Expanding Patient Care Through Clinical Pharmacy Services in Modern Healthcare
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmacovigilance
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Sophy S”
